- Research article
- Open Access
Daurisoline attenuates H2O2-induced chondrocyte autophagy by activating the PI3K/Akt/mTOR signaling pathway
Journal of Orthopaedic Surgery and Research volume 18, Article number: 248 (2023)
Osteoarthritis (OA) is a chronic degenerative joint disease characterized by cartilage degeneration and intra-articular inflammation. Daurisoline (DAS) is an isoquinoline alkaloid isolated from Rhizoma Menispermi, whose antitumor and anti-inflammatory pharmacological effects have been demonstrated, but the effects of DAS on OA have rarely been researched. In this study, we aimed to explore the potential role of DAS in OA and its partial mechanism.
Materials and methods
The cytotoxicity of H2O2 and DAS toward chondrocytes was detected by the Cell Counting Kit-8 assay. Safranin O staining was used to detect chondrocyte phenotype changes. Cell apoptosis was measured by both flow cytometry and quantitative analysis of the protein levels of the apoptosis-related factors Bax, Bcl-2 and cleaved caspase-3 by western blot. Western blotting and immunofluorescence were used to assess the expression of the autophagy-related proteins LC3, Beclin-1 and p62. In addition, key signal pathway targets and matrix-degrading indicators were measured by western blot.
Our results indicated that H2O2 induced human chondrocyte apoptosis and activated autophagy in a dose-dependent manner. DAS treatment dose-dependently reversed the expression of apoptosis-related proteins (Bax, Bcl-2 and cleaved caspase3) and the apoptosis rate induced by H2O2. Western blot and immunofluorescence analyses showed that DAS decreased the H2O2-induced upregulation of the autophagy marker Beclin-1 and the LC3 II/LC3 I ratio and upregulated the p62 protein level. Mechanistically, DAS inhibited autophagy through the activation of the classical PI3K/AKT/mTOR signaling pathway and protected chondrocytes from apoptosis. In addition, DAS alleviated the H2O2-induced degradation of type II collagen and the high expression of matrix metalloproteinase 3 (MMP3) and MMP13.
Our research demonstrated that DAS alleviated chondrocyte autophagy caused by H2O2 through activation of the PI3K/AKT/mTOR signaling pathway and protected chondrocytes from apoptosis and matrix degradation. In conclusion, these findings suggest that DAS may serve as a promising therapeutic strategy for OA.
With the acceleration of the global population aging trend, OA has become nearly universal among the middle and elderly worldwide [1, 2]. As a type of chronic degenerative joint disease, OA is characterized by progressive articular cartilage degeneration associated with multiple factors, such as metabolic disorders of the cartilage matrix, chondrocyte apoptosis, subchondral bone remodeling, and intra-articular inflammation [3,4,5]. The aggravation of the disease leads to total cartilage loss and destruction and ultimately causes limited movement, joint dysfunction, and even disability [6, 7]. Although some medications and physical therapy can alleviate OA symptoms and slow disease progression by improving cartilage metabolism and repairing cartilage, no effective treatment can reverse the progression of the disease [8, 9]. Therefore, it is imperative to research and develop more effective treatments.
Autophagy, which is closely related to apoptosis, is an intracellular metabolic pathway of self-degradation that is highly conserved. Autophagy provides extra energy for cells to combat antagonistic conditions, maintain intracellular homeostasis, and regulate the physiological function of cells by eliminating abnormal organelles and unnecessary proteins [10,11,12]. Autophagy is activated under oxidative stress, but excessive oxidative stress that exceeds the tolerance of cells will cause dysfunctional autophagy . Unrestrained autophagy may lead to autophagic injury and cell apoptosis and even aggravate disease progression [14,15,16].
Autophagy is involved in physiological processes such as apoptosis regulation and energy metabolism in chondrocytes. In the initial phase of OA, autophagy acts as an adaptable reaction to prevent cell damage. However, excessive autophagy can be activated along with apoptosis as a substitute for cell death in the later period of OA . Autophagic cell death promotes chondrocyte apoptosis and further exacerbates cartilage degeneration. Therefore, chondrocyte therapy based on the regulation of autophagy might be an essential strategy for OA treatment.
Plant-derived traditional Chinese medicine has attracted increasing attention by virtue of its efficacy and safety [18, 19]. Daurisoline (DAS) is an isoquinoline extracted from the Chinese herbal medicine Rhizoma Menispermi. Earlier research has shown the potential pharmacological effects of DAS for treating certain diseases, such as its modulation of focal ischemia/reperfusion injury, platelet aggregation, and arrhythmia [20, 21]. Furthermore, DAS has potential autophagy inhibition and exhibits anti-inflammatory and antitumor activity [22,23,24]. The potential bioactivity of DAS on OA, especially for autophagy, and its underlying mechanisms remain uncertain. This study established a chondrocyte damage model by treating chondrocytes with H2O2, aiming to explore the role of DAS in antioxidative autophagy and elucidate some of its mechanism of action. Furthermore, the effect of DAS on articular cartilage degeneration was investigated for the first time in vitro and in vivo, hoping to provide a new therapeutic strategy for OA.
Materials and methods
Patients and ethics statement
In this study, 20 patients with OA who underwent knee arthroplasty surgery at the Second Hospital of Shandong University from May 2020 to June 2021 were selected for primary human chondrocyte extraction. OA was diagnosed according to the American College of Rheumatology (ACR) knee OA criteria, and it was classified based on the Kellgren-Lawrence scoring system. The number of patients with each grade was 12 with grade 2 and 8 with grade 3. Our study was approved by the Ethics Committee of the Second Hospital of Shandong University (approval number: KYLL-2020LKJOA-0026). In addition, all patients signed the informed consent form.
Primary human chondrocyte extraction and culture
Chondrocytes were isolated from cartilage tissue samples taken from all 20 patients with OA included in the study. We only selected macroscopic healthy specimens around the joint wear surface for cell extraction [25, 26]. Briefly, the cartilage tissues were washed with PBS 3 times to remove residual blood. Next, we cut the cartilage tissue into pieces of approximately 1 mm3 with ophthalmic scissors, placed they into a centrifuge tube, and added PBS to wash they three times. The cartilage tissue was digested with 0.2% type II collagenase overnight at 37 °C. The cells were separated from the digested cartilage tissue with a 200-mesh filter. After centrifugation of the cell suspension with the supernatant removed, chondrocytes were seeded in DMEM/F12 medium containing 10% fetal bovine serum (HyClone, USA) and incubated at 37 °C in an incubator with 5% CO2. After a 3-day incubation, the cell growth status was investigated, and the medium was replaced. The culture medium was changed every 3 days. The cells were passaged when they had grown to 80% to 90% confluency. The chondrocytes were used in experiments after at least three passages.
Cell viability analysis
The cytotoxicity of H2O2 and DAS on chondrocytes was detected by the Cell Counting Kit-8 (CCK-8; Beyotime, Beijing, China) assay. Primary human chondrocytes (3000 cells per well) were seeded in a 96-well plate for 24 h for preincubation. First, H2O2 (Aladdin, Shanghai, China) and DAS (Yuanye Bio-technology Co, Shanghai, China, cat. no. B20095) were used to stimulate cells, and then 10 μl of CCK-8 dye was added to each well, followed by incubation in a 96-well plate at 37 °C protected from light for 2–3 h. The absorbance value (OD value) of each well at a wavelength of 450 nm was calculated by a microplate reader (Bio-Rad, USA).
Safranin O staining
Safranin O staining was used to detect chondrocyte phenotype changes. Briefly, chondrocytes were seeded in 6-well plates, prestimulated with H2O2 (200 μM) for 4 h, and then treated with DAS (2.5 and 5 μM) for 24 h. Next, the cells were fixed with 4% paraformaldehyde at room temperature for 30 min. After being washed with PBS three times, the cells were stained with safranin O solution (Solarbio, Beijing, China) at a concentration of 0.1% for 5–10 min. Finally, the cells were washed with PBS three times and then imaged by light microscopy (Leica, Germany, magnification ×100). The statistical processing was done with ImageJ, and values were normalized to the control group.
Chondrocytes were seeded in 96-well or 6-well plates and treated with different concentrations of H2O2 (0, 10, 50, 100, 200, 300, 400 and 500 μM) and DAS (0, 1, 2.5, 5, 10, 15 and 20 μM) for 4 h and 24 h to detect cell viability and chondrocyte phenotypic changes. Based on these results, for experiments the cells were pretreated with DAS (2.5 and 5 μM) for 24 h and stimulated with H2O2 (200 μM) for 4 h. In addition, cells were collected for a western blot assay to determine the levels of autophagy markers and apoptosis-related factors, and immunofluorescence was performed to test Beclin-1. To detect the involved signal pathways, we divided the cells into 4 groups that underwent different treatments: control group, H2O2, H2O2 + DAS and H2O2 + IGF-1 as a PI3K/Akt/mTOR pathway activator to stimulate chondrocytes. We detected changes in related factors by western blot.
Protein extraction and western blot
After appropriate treatment, cells were lysed for total protein extraction by RIPA Lysis Buffer (Beyotime) containing protease and phosphatase inhibitors, and the protein concentration was measured using a BCA assay kit (Beyotime, Beijing, China). Then, 20 μg of whole proteins from each group was loaded into 10% or 12% sodium dodecyl sulfate‒polyacrylamide gel electrophoresis (SDS-PAGE) gels for separation and transferred to polyvinylidene difluoride (PVDF) membranes. The membranes were blocked with TBST supplemented with 5% nonfat dried milk and incubated with primary antibodies at 4 °C overnight. Primary antibodies against LC3B (1:1000, CST), p62 (1:2000, Abcam), Beclin-1 (1:1000, CST), BAX (1:1000, Abcam), Bcl-2 (1:2000, Abcam), caspase-3 (1:1000, CST), PI3K (1:500, CST), p-PI3K (1:500, CST), AKT (1:500, CST), p-AKT (1:500, CST), mTOR (1:500, CST), p-mTOR (1:500, CST), Collagen II (1:500, Abcam), MMP-3 (1:1000, CST) and MMP-13 (1:1000, CST) were used in this study. After washing the membranes three times, the membranes were incubated with the relevant secondary antibodies for 1 h at room temperature. The protein bands were evaluated by an enhanced ECL kit (Millipore, USA) and a Chemiluminescence Imaging System (Tanon-4800, Shanghai, China), and the data were analyzed by ImageJ software (National Institutes of Health, USA).
Apoptosis of chondrocytes was evaluated by an annexin V-fluorescein isothiocyanate (FITC)/PI kit (Bestbio, China). Briefly, chondrocytes were seeded into 6-well plates and treated for 6 h with serum-free DMEM to ensure synchronization. Next, chondrocytes were treated accordingly with the indicated concentrations of H2O2 and DAS. After treating the cells with 0.25% trypsin, the cells were collected, rinsed twice with PBS, centrifuged, and resuspended in 100 μl binding buffer. The cell suspension was then thoroughly mixed with 5 μl of annexin V-FITC staining solution and 5 μl propidium iodide (PI) and kept in the dark at room temperature for 15 min, followed by the addition of 400 μl of 1× binding buffer. Cell apoptosis was detected by flow cytometry (BD Accuri™ C6 Plus) at a wavelength of 488 nm. The data were analyzed using FlowJo V10.8.1 software (Tree Star).
Chondrocytes were seeded into 20-mm confocal Petri dishes and starved with serum-free DMEM for 24 h after their confluency reached 80%. We then randomly divided chondrocytes into H2O2, H2O2 + DAS, and control groups. After washing three times with PBS, the cells were fixed for 15 min with 4% paraformaldehyde and then permeabilized with PBS containing 0.3% Triton X-100 for 15 min, followed by a PBS wash. At room temperature, the cells were blocked with 5% BSA for 1 h. Afterward, the samples were incubated with the rabbit anti-human Beclin-1 antibody (Abcam, Britain; 1:200) at 4 °C overnight. Next, the samples were washed with PBS 3 times and incubated with fluorescein isothiocyanate-conjugated secondary antibody for 1 h at room temperature in the dark. Finally, we stained the cell nuclei with DAPI in darkness for 5 min and sealed the slides with an anti-fluorescent quenching agent. Immunofluorescence analysis was performed with a Leica DMi8 fluorescence microscope. The intensity of fluorescence was measured using ImageJ and normalized to the DAPI signal.
Experimental data were analyzed using GraphPad Prism 8.0 (GraphPad Software Inc., San Diego, California, USA), and the measurements are expressed as mean ± standard deviation (SD). The two groups were compared using Student’s t test. One-way ANOVA was used for intergroup comparisons of > 3 groups. At least three independent replicate experiments were done to obtain all data. Differences were statistically significant at P < 0.05 and are marked with *P < 0.05, **P < 0.01, and ***P < 0.001.
H2O2 activates apoptosis and autophagy in human chondrocytes
The H2O2-induced chondrocyte damage model is considered a classical in vitro model of OA, which we made with reference to the experimental methods of previous studies [27, 28]. To assess the toxicity of H2O2 on chondrocytes, cells were stimulated with incremental doses of H2O2 for 4 h. The CCK-8 results indicated that chondrocytes were exposed to H2O2 for 4 h to inhibit activity in a dose-dependent fashion, and doses above 200 μM H2O2 had a significant inhibitory effect (Fig. 1A). Therefore, we selected 200 µM H2O2 for subsequent experiments. To search for the potential mechanism of reduced cell activity, we examined chondrocyte apoptosis and autophagy. To explore the apoptosis response of H2O2-stimulated human chondrocytes, we selected different doses of H2O2 (0, 10, 50, 100, 200 and 300 µM) to stimulate cells. After treatment for 24 h, the protein expression levels of Bax, cleaved-caspase3 and Bcl-2 were detected by western blot. As shown in Fig. 1B–E, H2O2 increased the expression of the proapoptotic proteins Bax and cleaved caspase3 and decreased the expression of the antiapoptotic protein Bcl-2 in a concentration-dependent manner. We also examined the effect of H2O2 on chondrocyte autophagy. The results showed that H2O2 enhanced the expression of the autophagy markers LC3-II/LC3-I and Beclin-1 in a concentration-dependent manner (Fig. 1F–H). The apoptosis and autophagy reactions of chondrocytes showed the same enhancement trend after H2O2 treatment. We speculate that overactivated autophagy exacerbated the apoptosis of chondrocytes.
Effect of DAS on human chondrocyte viability and maintenance of cell phenotype
The chemical properties of DAS are shown in Fig. 2A. To assess the effect of DAS on chondrocytes, cells were treated with various doses of DAS for 24 h. According to Fig. 2B, DAS showed no significant toxicity on cells at doses of 0.5, 1, 2.5 and 5 μM. We further investigated the influence of two experimental concentrations of DAS (2.5 and 5 μM) on chondrocyte viability at different treatment times (12, 24, 48 and 72 h). As shown in Fig. 2C, DAS with a treatment time ≤ 48 h had no obvious toxic effect on chondrocytes, but when the treatment time was longer than 48 h, the cell activity was significantly reduced. When chondrocytes were pretreated with DAS at different concentrations (0.5, 1, 2.5 and 5 μM) for 24 h and then cultivated with or without H2O2 (200 μM) for 4 h, cell viability was significantly restored by the pretreatment, and the most protective concentration was 5 μM (Fig. 2D). Based on these data, DAS was added at concentrations of 2.5 and 5 μM was for further experiments. Next, morphological analysis of chondrocytes after different treatments was performed by phase-contrast microscopy. According to Fig. 2E, the number of cell colonies decreased after H2O2 treatment compared to the control value, while DAS effectively prevented H2O2-induced cell depletion. The effect of DAS on the chondrocyte phenotype was also tested by Safranin O staining, which yielded similar results. The application of DAS increased the secretion of glycosaminoglycan (GAG) by chondrocytes and prevented matrix degradation (Fig. 2F–G).
DAS alleviates H2O2-induced human chondrocyte apoptosis
To assess the effect of DAS on human chondrocyte apoptosis, we measured the expression of apoptosis-related factors by western blot. Chondrocytes were pretreated with DAS for 24 h and then incubated with or without H2O2 (200 μM) for 4 h. As shown in Fig. 3A–D, DAS (2.5 or 5 μM) inhibited the H2O2-induced upregulation of pro-apoptotic Bax and cleaved-caspase3 proteins, whereas it increased the expression of anti-apoptotic Bcl-2. Notably, treatment with 5 μM DAS resulted in a more marked recovery of apoptosis-related protein expression than the dose of 2.5 μM. Subsequently, flow cytometry was used to measure the proportion of apoptotic cells, and similar results were obtained. According to Fig. 3E–F, the apoptosis rate in the H2O2 group (33.62%) was significantly greater than that in the control group (15.39%), but the apoptosis rate decreased to 25.82% after DAS treatment. The above results showed that DAS protected chondrocytes from H2O2-induced apoptosis.
DAS downregulates the level of autophagy in chondrocytes
To clarify whether autophagy participates in the protective effect of DAS against H2O2-induced chondrocyte apoptosis, we detected the expression of autophagy markers. As shown in Fig. 4A–D, under H2O2 treatment, the autophagy markers LC3 and Beclin-1 increased, and the protein level of p62 was significantly reduced. Under DAS pretreatment (2.5 and 5 μM), the expression of LC3-II/LC3-I and Beclin-1 were significantly downregulated, while the p62 protein level was upregulated. To further confirm the role of DAS in chondrocyte autophagy, immunofluorescence was performed to detect the expression of Beclin-1. As shown in Fig. 5A, B, H2O2 (200 μM, 4 h) significantly upregulated the expression of Beclin-1 compared to that in the control group, while treatment with DAS (5 μM, 24 h) significantly antagonized the increase in H2O2-induced Beclin-1 expression. These results indicated that DAS inhibited H2O2-induced excessive autophagy.
DAS activates the PI3K/AKT/mTOR signaling pathway
The PI3K/AKT/mTOR signaling pathway has been reported to play a crucial role in chondrocyte apoptosis and autophagy. Therefore, to better understand the mechanism through which DAS prevents H2O2-induced chondrocyte apoptosis and autophagy damage, we investigated the involvement of the PI3K/AKT/mTOR signaling pathway by western blot. As shown in Fig. 6A–D, compared to the control group, p-PI3K, p-AKT and p-mTOR levels were reduced in chondrocytes treated with H2O2, while their expression was upregulated in chondrocytes treated with DAS (2.5 and 5 μM). These data suggest that the activation of PI3K/Akt/mTOR signaling may be related to the mechanism by which DAS inhibits autophagy injury.
DAS inhibits autophagy marker expression through the PI3K/AKT/mTOR pathway and protects chondrocytes from apoptosis and matrix degradation
To further verify whether DAS inhibited anomalous chondrocyte autophagy via the PI3K/AKT/mTOR signaling pathway, we treated chondrocytes with insulin-like growth 1 as a positive control (IGF-1, a PI3K activator). The cells were divided into the following 4 groups: control, H2O2, H2O2 + DAS and H2O2 + IGF-1. Then, the expression of relevant proteins was analyzed by western blot. As shown in Fig. 7A–D, H2O2 significantly inhibited phosphorylation of the PI3K/AKT/mTOR signaling pathway, while the separate addition of DAS and IGF-1 upregulated the phosphorylation levels of H2O2-inhibited PI3K, AKT, and mTOR to varying degrees. The results of autophagy marker expression showed that DAS and IGF-1 blocked autophagy. Western blot analysis showed that DAS and IGF-1 inhibited the autophagy-related proteins LC3 and Beclin-1 and promoted the expression of p62 (Fig. 7E–H). In addition, we found that DAS and IGF-1 reduced the stimulating effect of H2O2 on the expression of cleaved caspase-3 and Bax protein and enhanced the expression of the anti-apoptotic factor Bcl-2, as shown in Fig. 7I–L.
As shown in Fig. 2E, we have preliminarily demonstrated the role of DAS in cartilage matrix metabolism. To further explore the effect of DAS on human chondrocytes, western blots were performed to detect the expression of the matrix component protein (collagen II) and matrix-degrading indicators (MMP-3 and MMP-13). The results showed that DAS significantly reversed the H2O2-induced downregulation of collagen II, inhibited the upregulation of MMP3 and MMP13, and blocked cartilage stromal decomposition (Fig. 8A–D). Therefore, DAS could protect human chondrocytes from stromal decomposition by restoring the H2O2-induced deletion of matrix component proteins and downregulating the expression of matrix-degrading proteins. In summary, DAS has a similar effect as IGF-1 and may block excessive autophagy and apoptosis of human chondrocytes by upregulating the activation of PI3K/AKT/mTOR signaling and alleviating cartilage matrix degradation.
Osteoarthritis is a chronic degenerative disease characterized by chronic intra-articular inflammation and articular cartilage degeneration, often resulting in chronic pain and joint disability, and is more prevalent in the elderly population [6, 29, 30]. While drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs) can relieve chronic pain and swelling caused by OA, the deterioration of OA is not effectively reversed. In addition, the long-term application of such drugs can cause a range of side effects . Therefore, finding safe and effective drugs to treat OA is imperative. In recent years, traditional Chinese medicine (TCM) has been recognized worldwide for its natural advantages . Daurisoline is an isoquinoline alkaloid mainly extracted from the Chinese herbal medicine Rhizoma Menispermi, which exhibits a wide range of pharmacological effects in the treatment of cardiovascular and cerebrovascular diseases, including anti-inflammatory and antitumor effects [20, 22, 23]. In this study, we investigated the effect and molecular mechanisms of DAS in H2O2-induced oxidative stress injury of chondrocytes and found that DAS alleviated H2O2-induced autophagy, apoptosis and cartilage matrix degradation in chondrocytes. The potential mechanism was associated with the activation of the PI3K/AKT/mTOR pathway in human OA chondrocytes.
Oxidative stress is one of the leading causes of OA pathogenesis. It plays a major pathological driving role in ECM degradation, chondrocyte apoptosis and the inflammatory response [33,34,35]. It affects chondrocyte homeostasis through multiple pathways, such as mitochondrial dysfunction, telomerase shortening and DNA damage. In this study, we used H2O2 to induce oxidative stress injury in human OA chondrocytes to mimic the OA cell model. As expected, H2O2 markedly reduced chondrocyte viability and GAG secretion and significantly activated cell apoptosis. Moreover, the administration of DAS promoted the recovery of cell viability and phenotype and alleviated H2O2-induced chondrocyte apoptosis. These data indicate that DAS has a protective effect against H2O2-induced chondrocyte injury.
Autophagy is a critical biological process of self-digestion. It is believed to play a dual role in the pathogenesis of OA . Many studies have shown that autophagy is intimately involved in the protection of cartilage lesions, and restoration of autophagy alleviates chondrocyte apoptosis in OA [37, 38]. On the other hand, when the degradation capacity of lysosomes is insufficient to eliminate the autophagosome contents, abnormal autophagy promotes the activation of the apoptotic cascade, and autophagy damage induces aging-related cell death and aggravates the progression of OA in patients [39, 40]. Therefore, autophagy in cartilage appears to be subtly regulated, and whether it is beneficial or harmful to the progression of OA depends on the balance between the amount of substrate and the capacity of the autophagy mechanism, and maintaining an appropriate level of autophagy under stress is crucial. In this study, we found that H2O2-induced autophagy markers LC3 and Beclin-1 were significantly increased in human chondrocytes, accompanied by increased apoptotic signals, such as increased Bax and decreased Bcl-2, suggesting that cartilage injury was caused by excessive autophagy-induced apoptosis. By detecting the protein expression of LC3II/LC3I, Beclin-1 and p62, we found that DAS strongly inhibited autophagy. In addition, immunofluorescence was used to detect Beclin-1 to determine whether DAS can inhibit chondrocyte autophagy. When autophagy was blocked by DAS, the expression of apoptosis-related proteins (Bax and cleaved caspase 3) was downregulated, the level of anti-apoptotic Bcl-2 was increased, and the percentage of apoptotic cells was also decreased. These findings suggest that DAS mitigated oxidative stress-induced apoptosis signaling by inhibiting excessive autophagy in chondrocytes, making this process a potential therapeutic target for OA.
Autophagy is controlled by the major negative regulator mTOR and its upstream regulator PI3K/Akt . In addition to mediating autophagy, the PI3K/Akt/mTOR signaling pathway affects various physiological and pathological processes, such as cell proliferation, differentiation, inflammation, apoptosis, and cancer . As the PI3K/Akt/mTOR pathway has been studied more, results have confirmed that the PI3K/AKT/mTOR pathway plays a role in apoptosis and autophagy of chondrocytes . Considering the above reasons, we speculated that the regulatory effect of DAS on autophagy in osteoarthritis chondrocytes might be realized through the PI3K/AKT/mTOR signaling pathway. In our study, DAS significantly activated H2O2-induced inhibition of the PI3K/AKT/mTOR signaling pathway. Furthermore, IGF-1 was employed to activate the PI3K/Akt/mTOR signaling pathway as a positive control. Our results suggested that both DAS and IGF-1 treatment reversed H2O2-induced autophagy, apoptosis and cartilage matrix degradation. Therefore, these data indicate that DAS can reverse H2O2-induced adverse outcomes through the PI3K/Akt/mTOR signaling pathway, establishing the relationship between DAS and the PI3K/Akt/mTOR signaling pathway. Activation of mTOR is known to inhibit autophagosome formation, and inhibition of mTOR pathway signaling leads to cell death related to apoptosis and autophagy [44, 45]. Therefore, we suspect that the inhibition of apoptosis induced by excessive autophagy is synergistic with the antiapoptotic effect of PI3K/AKT/mTOR signaling pathway activation, which makes the antiapoptotic effect of DAS more significant.
In summary, these results suggest that the potential mechanism by which DAS alleviates autophagy and apoptosis in chondrocytes is related to the activation of the PI3K/AKT/mTOR pathway. Whether PI3K/AKT/mTOR is a direct target of DAS remains unknown. Further studies are needed to elucidate the exact mechanism by which DAS regulates the PI3K/AKT/mTOR signaling pathway. In addition, the data obtained from in vitro experiments may differ from the results of in vivo experiments. Therefore, the curative effect of DAS on OA needs to be further studied.
This study preliminarily demonstrated that DAS inhibits chondrocyte apoptosis and improves inflammatory responses and matrix degradation in vitro by inhibiting H2O2-induced excessive autophagy. These effects may be mediated by activation of the PI3K/AKT/mTOR pathway. Our findings indicate the great potential of DAS in the treatment of OA. Future studies should focus on the efficacy and more comprehensive mechanisms of DAS in vivo, to determine whether there is strong evidence supporting the application of DAS in clinical trials.
Availability of data and materials
Data are available on request from the authors.
Bortoluzzi A, Furini F, Scirè CA. Osteoarthritis and its management—epidemiology, nutritional aspects and environmental factors. Autoimmun Rev. 2018;17(11):1097–104.
Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2021;17(1):47–57.
Al Faqeh H, Nor Hamdan BM, Chen HC, Aminuddin BS, Ruszymah BH. The potential of intra-articular injection of chondrogenic-induced bone marrow stem cells to retard the progression of osteoarthritis in a sheep model. Exp Gerontol. 2012;47(6):458–64.
Guilak F, Nims RJ, Dicks A, Wu CL, Meulenbelt I. Osteoarthritis as a disease of the cartilage pericellular matrix. Matrix Biol. 2018;71–72:40–50.
Burr DB, Gallant MA. Bone remodelling in osteoarthritis. Nat Rev Rheumatol. 2012;8(11):665–73.
Chen D, Shen J, Zhao W, Wang T, Han L, Hamilton JL, Im HJ. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res. 2017;5:16044.
Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745–59.
Cooper C, Chapurlat R, Al-Daghri N, Herrero-Beaumont G, Bruyère O, Rannou F, Roth R, Uebelhart D, Reginster JY. Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: What does the literature say? Drugs Aging. 2019;36(Suppl 1):15–24.
Lemes IR, Pinto RZ. Critically appraised paper: physiotherapy improved pain and functional disability more than glucocorticoid injection in people with knee osteoarthritis [commentary]. J Physiother. 2021;67(1):64.
Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008;451(7182):1069–75.
Rubinsztein DC, Mariño G, Kroemer G. Autophagy and aging. Cell. 2011;146(5):682–95.
Pierrefite-Carle V, Santucci-Darmanin S, Breuil V, Camuzard O, Carle GF. Autophagy in bone: self-eating to stay in balance. Ageing Res Rev. 2015;24(Pt B):206–17.
Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22(3):377–88.
Zhang M, Sui W, Xing Y, Cheng J, Cheng C, Xue F, Zhang J, Wang X, Zhang C, Hao P, Zhang Y. Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis. Theranostics. 2021;11(18):8624–39.
Mattiolo P, Yuste VJ, Boix J, Ribas J. Autophagy exacerbates caspase-dependent apoptotic cell death after short times of starvation. Biochem Pharmacol. 2015;98(4):573–86.
Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27–42.
Musumeci G, Castrogiovanni P, Trovato FM, Weinberg AM, Al-Wasiyah MK, Alqahtani MH, Mobasheri A. Biomarkers of chondrocyte apoptosis and autophagy in osteoarthritis. Int J Mol Sci. 2015;16(9):20560–75.
Liu JH, Zhao N, Zhang GJ, Yu SS, Wu LJ, Qu J, Ma SG, Chen XG, Zhang TQ, Bai J, Chen H, Fang ZF, Zhao F, Tang WB. Bioactive quassinoids from the seeds of Brucea javanica. J Nat Prod. 2012;75(4):683–8.
Zeng L, Wang W, Rong XF, Zhong Y, Jia P, Zhou GQ, Li RH. Chondroprotective effects and multi-target mechanisms of Icariin in IL-1 beta-induced human SW 1353 chondrosarcoma cells and a rat osteoarthritis model. Int Immunopharmacol. 2014;18(1):175–81.
Yang XY, Jiang SQ, Zhang L, Liu QN, Gong PL. Inhibitory effect of dauricine on inflammatory process following focal cerebral ischemia/reperfusion in rats. Am J Chin Med. 2007;35(3):477–86.
Lingenhöhl K, Small DL, Monette R, Buchan AM, Morley P, Allegrini PR, Fröst LW, Sauer D, Schmutz M, Knöpfel T. Exploration of P-type Ca2+ channels as drug targets for the treatment of epilepsy or ischemic stroke. Neuropharmacology. 1997;36(1):107–13.
Zhou J, Wu H, Hou J, Wang J, Wang J, Li M, Yao X, Gao J, Zhang Q. Daurisoline alleviated experimental colitis in vivo and in vitro: Involvement of NF-κB and Wnt/β-Catenin pathway. Int Immunopharmacol. 2022;108: 108714.
Huang XH, Yan X, Zhang QH, Hong P, Zhang WX, Liu YP, Xu WW, Li B, He QY. Direct targeting of HSP90 with daurisoline destabilizes β-catenin to suppress lung cancer tumorigenesis. Cancer Lett. 2020;489:66–78.
Zhang X, Zhang JG, Mu W, Zhou HM, Liu GL, Li Q. The role of daurisoline treatment in hepatocellular carcinoma: Inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib. Phytomedicine. 2021;92: 153740.
Wang FS, Kuo CW, Ko JY, Chen YS, Wang SY, Ke HJ, et al. Irisin mitigates oxidative stress, chondrocyte dysfunction and osteoarthritis development through regulating mitochondrial integrity and autophagy. Antioxidants. 2020;9(9):66.
Ansari MY, Khan NM, Haqqi TM. A standardized extract of Butea monosperma (Lam.) flowers suppresses the IL-1β-induced expression of IL-6 and matrix-metalloproteases by activating autophagy in human osteoarthritis chondrocytes. Biomed Pharmacother. 2017;96:198–207.
D’Adamo S, Cetrullo S, Guidotti S, Silvestri Y, Minguzzi M, Santi S, et al. Spermidine rescues the deregulated autophagic response to oxidative stress of osteoarthritic chondrocytes. Free Radic Biol Med. 2020;153:159–72.
Lim HD, Kim YS, Ko SH, Yoon IJ, Cho SG, Chun YH, Choi BJ, Kim EC. Cytoprotective and anti-inflammatory effects of melatonin in hydrogen peroxide-stimulated CHON-001 human chondrocyte cell line and rabbit model of osteoarthritis via the SIRT1 pathway. J Pineal Res. 2012;53(3):225–37.
Zheng L, Zhang Z, Sheng P, Mobasheri A. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. Ageing Res Rev. 2021;66: 101249.
van den Bosch MHJ. Osteoarthritis year in review 2020: biology. Osteoarthr Cartil. 2021;29(2):143–50.
Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, Kraus VB, Lohmander LS, Abbott JH, Bhandari M, Blanco FJ, Espinosa R, Haugen IK, Lin J, Mandl LA, Moilanen E, Nakamura N, Snyder-Mackler L, Trojian T, Underwood M, McAlindon TE. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27(11):1578–89.
Tian Z, Zhang X, Sun M. Phytochemicals mediate autophagy against osteoarthritis by maintaining cartilage homeostasis. Front Pharmacol. 2021;12: 795058.
Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(7):412–20.
Ansari MY, Ahmad N, Haqqi TM. Oxidative stress and inflammation in osteoarthritis pathogenesis: role of polyphenols. Biomed Pharmacother. 2020;129: 110452.
Jallali N, Ridha H, Thrasivoulou C, Underwood C, Butler PE, Cowen T. Vulnerability to ROS-induced cell death in ageing articular cartilage: the role of antioxidant enzyme activity. Osteoarthr Cartil. 2005;13(7):614–22.
Arias C, Salazar LA. Autophagy and polyphenols in osteoarthritis: a focus on epigenetic regulation. Int J Mol Sci. 2021;23(1):66.
Zhang X, Li Q, Sun Y, Chen L, Wang J, Liang L. Chondroitin sulfate from sturgeon bone protects rat chondrocytes from hydrogen peroxide-induced damage by maintaining cellular homeostasis through enhanced autophagy. Int J Biol Macromol. 2020;164:2761–8.
Kurakazu I, Akasaki Y, Tsushima H, Sueishi T, Toya M, Kuwahara M, Uchida T, Lotz MK, Nakashima Y. TGFβ1 signaling protects chondrocytes against oxidative stress via FOXO1-autophagy axis. Osteoarthr Cartil. 2021;29(11):1600–13.
Almonte-Becerril M, Navarro-Garcia F, Gonzalez-Robles A, Vega-Lopez MA, Lavalle C, Kouri JB. Cell death of chondrocytes is a combination between apoptosis and autophagy during the pathogenesis of Osteoarthritis within an experimental model. Apoptosis. 2010;15(5):631–8.
Hwang HS, Yang CM, Park SJ, Kim HA. Monosodium urate crystal-induced chondrocyte death via autophagic process. Int J Mol Sci. 2015;16(12):29265–77.
Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol. 2010;22(2):124–31.
Ersahin T, Tuncbag N, Cetin-Atalay R. The PI3K/AKT/mTOR interactive pathway. Mol Biosyst. 2015;11(7):1946–54.
Sun K, Luo J, Guo J, Yao X, Jing X, Guo F. The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthr Cartil. 2020;28(4):400–9.
Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 2015;125(1):25–32.
Will M, Qin AC, Toy W, Yao Z, Rodrik-Outmezguine V, Schneider C, Huang X, Monian P, Jiang X, de Stanchina E, Baselga J, Liu N, Chandarlapaty S, Rosen N. Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling. Cancer Discov. 2014;4(3):334–47.
The study was supported by grants from The Provincial Natural Youth Science Foundation of Shandong Province, China (ZR2020QH076).
Ethics approval and consent to participate
This study was approved by the Ethics Committee of Human Experimentation of Ethics Committee of Shandong University (Ethics Number: KYLL-2020LKJOA-0026). All patients signed informed consent forms.
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhang, Y., Liu, W., Liu, Z. et al. Daurisoline attenuates H2O2-induced chondrocyte autophagy by activating the PI3K/Akt/mTOR signaling pathway. J Orthop Surg Res 18, 248 (2023). https://doi.org/10.1186/s13018-023-03717-5
- PI3K/AKT/mTOR signaling pathway